Company Profile
Masimo Stock Price, News & Catalysts
- Ticker:
- MASI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
178.78 USD (+0.03%)
Close
Last updated: June 3, 2026
9.36B USD
Market cap
Why the stock is moving
Current closing-price context is not available for MASI.
Company overview
Noninvasive Patient Monitoring Company
Masimo develops monitoring technologies, sensors, software, and connected-care systems used across hospitals, emergency services, ambulatory settings, physician offices, home care, and long-term care facilities.
SET Pulse Oximetry
Masimo Signal Extraction Technology, or SET, is the company's foundational pulse-oximetry platform. It is designed to measure oxygen saturation and pulse rate during patient motion and low-perfusion conditions where conventional monitoring may be less reliable.
Rainbow Pulse CO-Oximetry
The rainbow platform extends monitoring beyond conventional pulse oximetry to parameters such as noninvasive hemoglobin. Masimo also offers brain-function, hemodynamic, regional-oximetry, capnography, gas-monitoring, acoustic-respiration, and related modalities.
Connected Monitoring and Hospital Automation
Root, Masimo SafetyNet, and the company's hospital-automation and connectivity products bring bedside and remote measurements into coordinated clinical workflows. These systems support centralized surveillance, telemonitoring, alarm management, and data exchange with hospital information systems.
Sensor and OEM Business Model
Masimo sells monitors and circuit boards together with proprietary single-patient and reusable sensors, software, cables, and services. Direct sales, distributors, and OEM relationships with major medical-equipment manufacturers broaden the installed base and support recurring sensor demand.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Masimo (MASI)?
Masimo (MASI) most recently closed at 178.78 USD, a +0.03% move versus the previous session.
What is the market cap of Masimo (MASI)?
Masimo currently has a market capitalization of 9.36B USD on BioPharmSignal.
What does Masimo do?
Noninvasive Patient Monitoring Company Masimo develops monitoring technologies, sensors, software, and connected-care systems used across hospitals, emergency services, ambulatory settings, physician offices, home care, and long-term care facilities. SET Pulse Oximetry Masimo Signal Extraction Technology, or SET, is the company's foundational pulse-oximetry...
On which exchange is MASI stock listed?
Masimo (MASI) is associated with NASDAQ, United States, Biopharma.
What is Noninvasive?
Noninvasive Patient Monitoring Company Masimo develops monitoring technologies, sensors, software, and connected-care systems used across hospitals, emergency services, ambulatory settings, physician offices, home care, and long-term care facilities.
Which conditions is Masimo targeting with Noninvasive?
Noninvasive Patient Monitoring Company Masimo develops monitoring technologies, sensors, software, and connected-care systems used across hospitals, emergency services, ambulatory settings, physician offices, home care, and long-term care facilities. SET Pulse Oximetry Masimo Signal Extraction Technology, or SET, is the company's foundational pulse-oximetry...
What is Patient?
Noninvasive Patient Monitoring Company Masimo develops monitoring technologies, sensors, software, and connected-care systems used across hospitals, emergency services, ambulatory settings, physician offices, home care, and long-term care facilities.
What is Monitoring?
Noninvasive Patient Monitoring Company Masimo develops monitoring technologies, sensors, software, and connected-care systems used across hospitals, emergency services, ambulatory settings, physician offices, home care, and long-term care facilities.